Oral candidiasis: The clinical challenge of resistance and management

International Journal of Antimicrobial Agents

Volumn 6, Issue 3, 1996, Pages 155-159

  Hoepelman, I M ^a   Dupont, B ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b INSTITUT PASTEUR   (France)

Author keywords

Management; Oral candidiasis; Resistance

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; CD4 ANTIGEN; CLOTRIMAZOLE; FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE; MICONAZOLE; NYSTATIN; PYRROLE DERIVATIVE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBIOTIC RESISTANCE; CANCER; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CONFERENCE PAPER; CROSS RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; MINIMUM INHIBITORY CONCENTRATION; MORBIDITY; PRIORITY JOURNAL; T LYMPHOCYTE; THRUSH;

EID: 0029927953     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/0924-8579(95)00050-X     Document Type: Conference Paper

References (23)

1. British Society for Antimicrobial Working Party. Antifungal chemotherapy in patients with acquired immunodeficiency syndrome. Lancet 1992;340:648-651.
2. Como JA, Dismukes WE. Oral azole drugs as systemic antifungal therapy. N Engl J Med 1994;330:263-272.
3. Epstein JB, Truelove EL, Izutzu KT. Oral candidiasis: pathogenesis and host defence. Rev Infect Dis 1984;6:96-106.
4. Bodey GP. Candidiasis in cancer patients. Am J Med 1984;77:13-19.
5. Dupont B. Resistant trends in oral Candida infections: the clinical challenge. Clinician 1993;11:19-22.
6. Anaissie E. Opportunistic mycoses in the immunocompromised host: experience at a cancer center and review. Clin Infect Dis 1992;14(suppl 1):S43-S53.
7. Meunier F, Aoun M, Bitar N. Candidemia in immunocompromised patients. Clin Infect Dis 1992;14(suppl 1):S120-S125.
8. Merz WG, Karp JE, Schron D et al. Increased incidence of fungemia caused by Candida krusei. J Clin Microbiol 1986;23:581-584.
9. Sangeorzan JA, Bradley SF, He X et al. Epidemiology or oral candidiasis in HIV-infected patients: colonization, infection, treatment, and emergence of fluconazole resistance. Am J Med 1994;97(suppl 4):339-346.
10. Laine L, Dretier RH, Conteas CN et al. Fluconazole compared with ketoconazole for the treatment of candida esophagitis in AIDS: a randomized trial. Ann Intern Med 1992;117:656-660.
11. Soil DR, Galask R, Schmid J, Hanna C, Mac K, Morrow B. Genetic dissimilarity of commensal strains of Candida spp. carried in different anatomical locations of the same healthy women. J Clin Microbiol 1991;29:1702-1710.
12. De Witt S, Weerts D, Goossens H, Clumeck N. Comparison of fluconazole and ketoconazole for oropharyngeal candidiasis in AIDS. Lancet 1989;746-747.
13. Baily GG, Perry FM, Denning DW, Mandal BK. Fluconazole-resistant candidiasis in an HIV cohort. AIDS 1994;8:787-792.
14. Barchiesi F, Hollis RJ, McGough DA, Scalise G, Rinaldi MG, Pfaller MA. DNA subtypes and fluconazole susceptibilities of C. albicans isolates from the oral cavities of patients with AIDS. Clin Infect Dis 1995;20:634-640.
15. Ruhnke M, Eigler A, Tennagen I, Geiseler B, Engelmann E, Trautmann M. Emergence of fluconazole-resistant stains of Candida albicans in patients with recurrent oropharyngeal candidiasis and human immunodeficiency virus infection. J Clin Microbiol 1994;32(suppl 9):2092-2098.
16. Goff DA, Koletau SI, Buesching WJ, Barnishan J, Fass RJ. Isolation of fluconazole-resistant C. albicans from human immunodeficiency virus - negative patients never treated with azoles. Clin Infect Dis 1995;20:77-83.
17. Cartledge JD, Midgley J, Youle M, Gazzard BG. Itraconazole cyclodextrin solution effective treatment for HIV-related candidiasis unresponsive to other azole therapy. J Antimicrob Chemother 1994;33:1071-1073.
18. Barchiesi F, Colombo AL, McGough DA, Fothergill AW, Rinaldi MG. In vitro activity of itraconazole against fluconazole-susceptible and resistant Candida albicans isolates from oral cavities of patients infected with human immunodeficiency virus. Antimicrob Chemother 1994;38(suppl 7):1530-1533.
19. Horn CA, Washburn RG, Givner LB, Peacock JE, Pegram PS. Azole resistant orophageal and esophageal candidiasis in patients with AIDS. AIDS 1995;9:533-534.
20. Rex JH, Pfaller MA, Rinaldi MG, Polau A, Galgiani TW. Antifungal susceptibility testing. Clin Microbiol Rev 1993;6:367-381.
21. Powderly WG, Finkelstein DM, Feinberg J et al. A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. N Engl J Med 1995;332:700-705.
22. Cartledge JD, Denning D, Dupont B et al. Treatment of fluconazole resistant oral candidosis with D0870 in patients with AIDS. 34th ICAAC, Orlando, Florida, USA, 4-7 October 1994. Antimicrob Agents Chemother 1994;34(suppl):248.
23. Colombo A, Barchiesi F, McGough DA, Fothergill AW, Bolmström A, Rinaldi MG. Antifungal susceptibility testing of yeasts with Etest azole strips: a comparison with the NCCLS macrobroth dilution in the evaluation of 80 clinical yeast isolates. Poster PO2.56, ISHAM, Adelaide, Australia, 1994.